FI943421A - 1,5-bensodiazepinderivat och deras användning som medicin - Google Patents
1,5-bensodiazepinderivat och deras användning som medicin Download PDFInfo
- Publication number
- FI943421A FI943421A FI943421A FI943421A FI943421A FI 943421 A FI943421 A FI 943421A FI 943421 A FI943421 A FI 943421A FI 943421 A FI943421 A FI 943421A FI 943421 A FI943421 A FI 943421A
- Authority
- FI
- Finland
- Prior art keywords
- medicine
- benzodiazepine derivatives
- benzodiazepine
- derivatives
- Prior art date
Links
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical class N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201180A GB9201180D0 (en) | 1992-01-21 | 1992-01-21 | Chemical compounds |
| GB9201180 | 1992-01-21 | ||
| EP9300098 | 1993-01-19 | ||
| PCT/EP1993/000098 WO1993014074A1 (en) | 1992-01-21 | 1993-01-19 | 1,5-benzodiazepine derivatives and their use in medicine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI943421A0 FI943421A0 (sv) | 1994-07-19 |
| FI943421A true FI943421A (sv) | 1994-07-19 |
| FI111632B FI111632B (sv) | 2003-08-29 |
Family
ID=10708914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943421A FI111632B (sv) | 1992-01-21 | 1994-07-19 | Förfarande för framställning av CCK-B-antagonistiskt verkande 1,5-bensodiazepinderivat |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5580895A (sv) |
| JP (1) | JP3253723B2 (sv) |
| KR (1) | KR100263625B1 (sv) |
| CN (1) | CN1049217C (sv) |
| AP (1) | AP369A (sv) |
| AU (2) | AU3450193A (sv) |
| BG (1) | BG61876B1 (sv) |
| CA (1) | CA2087672C (sv) |
| CZ (1) | CZ283950B6 (sv) |
| FI (1) | FI111632B (sv) |
| GB (1) | GB9201180D0 (sv) |
| GE (1) | GEP20001968B (sv) |
| HU (2) | HU221297B1 (sv) |
| IL (1) | IL104447A (sv) |
| IS (1) | IS3970A (sv) |
| MX (1) | MX9300261A (sv) |
| MY (1) | MY131307A (sv) |
| NO (1) | NO305952B1 (sv) |
| NZ (1) | NZ245715A (sv) |
| OA (1) | OA09964A (sv) |
| PH (1) | PH30894A (sv) |
| PL (1) | PL175340B1 (sv) |
| RO (1) | RO114128B1 (sv) |
| RU (1) | RU2124009C1 (sv) |
| SK (1) | SK280173B6 (sv) |
| TW (1) | TW226013B (sv) |
| UA (1) | UA29416C2 (sv) |
| WO (1) | WO1993014074A1 (sv) |
| ZA (1) | ZA93375B (sv) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9225492D0 (en) * | 1992-12-05 | 1993-01-27 | Glaxo Group Ltd | Amine derivatives |
| GB9307833D0 (en) * | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
| HUT74091A (en) * | 1993-04-15 | 1996-11-28 | Glaxo Wellcome Inc | 1,5-benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| GB9308431D0 (en) * | 1993-04-23 | 1993-06-09 | Glaxo Spa | Chemical compounds |
| GB9308421D0 (en) * | 1993-04-23 | 1993-06-09 | Glaxo Spa | Chemical compounds |
| GB9314981D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Spa | Chemical compounds |
| GB2280182A (en) * | 1993-07-20 | 1995-01-25 | Glaxo Spa | Benzodiazepine derivatives |
| GB9315018D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Spa | Chemical compounds |
| GB9314977D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Spa | Chemical compounds |
| AU697349B2 (en) * | 1994-04-14 | 1998-10-01 | Glaxo Wellcome Inc. | CCK or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| US5739129A (en) * | 1994-04-14 | 1998-04-14 | Glaxo Wellcome Inc. | CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines |
| PE27497A1 (es) * | 1994-04-15 | 1997-08-07 | Glaxo Inc | Derivados de 1,5 benzodiazepina |
| GB9420748D0 (en) * | 1994-10-14 | 1994-11-30 | Glaxo Inc | 1,5 benzodiazepine derivatives |
| US5780464A (en) * | 1994-10-14 | 1998-07-14 | Glaxo Wellcome Inc. | Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| AU715611B2 (en) | 1995-12-11 | 2000-02-03 | New England Medical Center Hospitals, Inc., The | Assay for and uses of peptide hormone receptor ligands |
| US5750353A (en) * | 1995-12-11 | 1998-05-12 | New England Medical Center Hospitals, Inc. | Assay for non-peptide agonists to peptide hormone receptors |
| CA2274669C (en) * | 1996-12-10 | 2006-11-14 | Zeria Pharmaceutical Co., Ltd. | 1,5-benzodiazepine derivatives |
| ATE552236T1 (de) * | 2003-01-14 | 2012-04-15 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz |
| GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| NZ547880A (en) * | 2003-11-18 | 2010-02-26 | Boehringer Ingelheim Int | Solid pharmaceutical preparation form |
| PL1765327T3 (pl) | 2004-06-17 | 2015-01-30 | Cytokinetics Inc | Związki, kompozycje i sposoby |
| US7538223B2 (en) | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| US7718657B2 (en) | 2005-12-16 | 2010-05-18 | Cytokinetics, Inc. | Certain indanyl urea modulators of the cardiac sarcomere |
| EP1962852B1 (en) | 2005-12-19 | 2017-01-25 | Cytokinetics, Inc. | Compounds, compositions and methods |
| CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| WO2013018690A1 (ja) | 2011-07-29 | 2013-02-07 | 国立大学法人徳島大学 | Erap1由来ペプチド及びその使用 |
| CN103435562B (zh) * | 2013-08-26 | 2016-02-24 | 华东理工大学 | 6-取代苯并二氮卓-2,4-二酮类化合物及其用途 |
| ES2928343T3 (es) | 2015-07-22 | 2022-11-17 | Enanta Pharm Inc | Derivados de benzodiazepina como inhibidores de RSV |
| US20170226129A1 (en) | 2016-01-15 | 2017-08-10 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| MX2019009687A (es) | 2017-02-16 | 2019-12-18 | Enanta Pharm Inc | Procesos para la preparación de derivados de benzodiazepina. |
| US10752598B2 (en) * | 2017-06-07 | 2020-08-25 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as RSV inhibitors |
| US10851115B2 (en) | 2017-06-30 | 2020-12-01 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| WO2019006295A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| CN111386118B (zh) | 2017-09-29 | 2023-05-09 | 英安塔制药有限公司 | 作为rsv抑制剂的组合药物剂 |
| US10647711B2 (en) | 2017-11-13 | 2020-05-12 | Enanta Pharmaceuticals, Inc. | Azepin-2-one derivatives as RSV inhibitors |
| US10975094B2 (en) | 2018-04-11 | 2021-04-13 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| EP3889264A4 (en) | 2018-11-30 | 2022-10-12 | Tokushima University | BREAST CANCER THERAPEUTIC WITH BIG3-PHB2 INTERACTION INHIBITING PEPTIDE FROM PHB2 |
| KR20210138684A (ko) | 2019-03-18 | 2021-11-19 | 이난타 파마슈티칼스, 인코포레이티드 | Rsv 억제제로서의 벤조디아제핀 유도체 |
| US11179400B2 (en) | 2019-04-09 | 2021-11-23 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
| WO2022010882A1 (en) | 2020-07-07 | 2022-01-13 | Enanta Pharmaceuticals, Inc, | Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors |
| WO2022086840A1 (en) | 2020-10-19 | 2022-04-28 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2641280B1 (fr) * | 1988-12-29 | 1994-01-21 | Roussel Uclaf | Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments |
-
1992
- 1992-01-21 GE GEAP19922651A patent/GEP20001968B/en unknown
- 1992-01-21 GB GB929201180A patent/GB9201180D0/en active Pending
-
1993
- 1993-01-15 US US08/256,359 patent/US5580895A/en not_active Expired - Fee Related
- 1993-01-19 WO PCT/EP1993/000098 patent/WO1993014074A1/en active IP Right Grant
- 1993-01-19 RO RO94-01216A patent/RO114128B1/ro unknown
- 1993-01-19 CZ CZ941736A patent/CZ283950B6/cs not_active IP Right Cessation
- 1993-01-19 RU RU94037768A patent/RU2124009C1/ru active
- 1993-01-19 SK SK864-94A patent/SK280173B6/sk unknown
- 1993-01-19 PL PL93304684A patent/PL175340B1/pl unknown
- 1993-01-19 HU HU9402150A patent/HU221297B1/hu not_active IP Right Cessation
- 1993-01-19 KR KR1019940702491A patent/KR100263625B1/ko not_active IP Right Cessation
- 1993-01-19 UA UA94005364A patent/UA29416C2/uk unknown
- 1993-01-19 AU AU34501/93A patent/AU3450193A/en not_active Abandoned
- 1993-01-20 IS IS3970A patent/IS3970A/is unknown
- 1993-01-20 PH PH45583A patent/PH30894A/en unknown
- 1993-01-20 MX MX9300261A patent/MX9300261A/es not_active IP Right Cessation
- 1993-01-20 AP APAP/P/1993/000478A patent/AP369A/en active
- 1993-01-20 MY MYPI93000093A patent/MY131307A/en unknown
- 1993-01-20 CA CA002087672A patent/CA2087672C/en not_active Expired - Fee Related
- 1993-01-20 IL IL104447A patent/IL104447A/en not_active IP Right Cessation
- 1993-01-20 ZA ZA93375A patent/ZA93375B/xx unknown
- 1993-01-20 AU AU31935/93A patent/AU661749B2/en not_active Ceased
- 1993-01-20 JP JP02483193A patent/JP3253723B2/ja not_active Expired - Fee Related
- 1993-01-20 NZ NZ245715A patent/NZ245715A/en unknown
- 1993-01-21 CN CN93101143A patent/CN1049217C/zh not_active Expired - Fee Related
- 1993-02-02 TW TW082100666A patent/TW226013B/zh active
-
1994
- 1994-06-27 BG BG98881A patent/BG61876B1/bg unknown
- 1994-07-18 OA OA60539A patent/OA09964A/en unknown
- 1994-07-19 FI FI943421A patent/FI111632B/sv active
- 1994-07-20 NO NO942720A patent/NO305952B1/no unknown
-
1995
- 1995-06-16 HU HU95P/P00242P patent/HU211295A9/hu unknown
-
1996
- 1996-07-01 US US08/674,259 patent/US5637697A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI943421A0 (sv) | 1,5-bensodiazepinderivat och deras användning som medicin | |
| FI953479A (sv) | 1-arylpyrimidinderivat och farmaceutisk användning av dessa | |
| FI943570A (sv) | 1-bensensulfonyl-1,3-dihydroindol-2-onderivat, framställning av dessa och läkemedel som innehåller dessa | |
| ATE163539T1 (de) | Arzneimittel | |
| FI932655A (fi) | Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat | |
| AU8650291A (en) | Iridoid derivatives and their use as medicines | |
| FI954491A (sv) | Heterocykler innehållande imidinderivat, deras framställning och användning | |
| FI930574A0 (fi) | Med keramiskt pigment oeverdragna oxidbaserade haorda partiklar, foerfarande foer framstaellning och anvaendning av dessa | |
| FI941287A0 (sv) | Triazolokinoxalin-1,4-dioner och framställning och användning av dem | |
| FI101382B1 (sv) | Dihydroxipropylsulfoetylcellulosor, framställning och användning av dem | |
| FI955679A (sv) | Piperidinderivater, framställning och användning därav | |
| EE03690B1 (et) | Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine | |
| FI961977A0 (sv) | N-substituerade azabicykloalkanderivat, deras framställning och användning | |
| FI933376A (fi) | 4-amino-3-acylkinolinderivater och deras anvaendning som inhibitorer avmagsyrasekretion | |
| NO308251B1 (no) | Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme | |
| FI933605A0 (fi) | Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler | |
| FI955335A0 (fi) | Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa | |
| FI942468A (sv) | Kemiska föreningar, deras framställning och användning | |
| EE03441B1 (et) | 5-naftalen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| BR9106372A (pt) | Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico | |
| NO942228D0 (no) | Ipsapiron-legemiddeltilberedning | |
| MX9205375A (es) | Nuevos derivados de bencilamina y el medicamento que los contienen. | |
| GB9206062D0 (en) | Heterocyclic compounds,their preparation and pharmaceutical use | |
| FI934317A0 (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
| FI935915A (sv) | 2-tienyl-imidazo(2,1-b)bensotiazol-3-aettiksyraderivat, deras framstaellning och terapeutisk anvaendning |